Advertisement
Screener

LISATA THERAPEUTICS, INC. (LSTA) Operating Leases, Rent Expense

1.6 / 5 stars · 15/46 Roast Me

LISATA THERAPEUTICS, INC. Operating Leases, Rent Expense

LISATA THERAPEUTICS, INC. (LSTA) reported Operating Leases, Rent Expense of $800.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:LeaseAndRentalExpense · last filed 2019-03-14

  • LISATA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-12-31 was $100.00K, a 66.67% decline year-over-year.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-09-30 was $200.00K, a 33.33% decline year-over-year.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $200.00K, a 50.00% decline year-over-year.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $300.00K, a 25.00% decline year-over-year.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2018 was $800.00K, a 42.86% decline from fiscal 2017.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2017 was $1.40M, a 0.00% change from fiscal 2016.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2016 was $1.40M, a 17.65% decline from fiscal 2015.
  • LISATA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2015 was $1.70M, a 30.77% increase from fiscal 2014.
Period endOperating Leases, Rent Expense 3 monthOperating Leases, Rent Expense 3 month as first filedOperating Leases, Rent Expense 6 monthOperating Leases, Rent Expense 6 month as first filedOperating Leases, Rent Expense 9 monthOperating Leases, Rent Expense 12 monthOperating Leases, Rent Expense 12 month as first filed
2018-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$300.00K
derived: sum of 2 quarters · filed 2019-03-14
$500.00K
derived: sum of 3 quarters · filed 2019-03-14
$800.00K
10-K · filed 2019-03-14
2018-09-30$200.00K
10-Q · filed 2018-11-08
$400.00K
derived: sum of 2 quarters · filed 2018-11-08
$700.00K
10-Q · filed 2018-11-08
$1.00M
derived: sum of 4 quarters · filed 2019-03-14
2018-06-30$200.00K
10-Q · filed 2018-08-09
$500.00K
10-Q · filed 2018-08-09
$800.00K
derived: sum of 3 quarters · filed 2019-03-14
$1.10M
derived: sum of 4 quarters · filed 2019-03-14
2018-03-31$300.00K
10-Q · filed 2018-05-10
$600.00K
derived: sum of 2 quarters · filed 2019-03-14
$900.00K
derived: sum of 3 quarters · filed 2019-03-14
$1.30M
derived: sum of 4 quarters · filed 2019-03-14
2017-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$600.00K
derived: sum of 2 quarters · filed 2019-03-14
$1.00M
derived: sum of 3 quarters · filed 2019-03-14
$1.40M
10-K · filed 2019-03-14
2017-09-30$300.00K
10-Q · filed 2018-11-08
$700.00K
derived: sum of 2 quarters · filed 2018-11-08
$1.10M
10-Q · filed 2018-11-08
$1.50M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$400.00K
10-Q · filed 2018-08-09
$700.00K
10-Q · filed 2018-08-09
$1.20M
derived: sum of 3 quarters · filed 2018-08-09
$1.50M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$400.00K
10-Q · filed 2018-05-10
$500.00K
10-Q · filed 2017-05-15
$800.00K
derived: sum of 2 quarters · filed 2018-05-10
$1.10M
derived: sum of 3 quarters · filed 2018-05-10
$1.40M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
$700.00K
derived: sum of 2 quarters · filed 2018-03-22
$1.00M
derived: sum of 3 quarters · filed 2018-03-22
$1.40M
10-K · filed 2018-03-22
$2.10M
10-K · filed 2017-03-17
2016-09-30$300.00K
10-Q · filed 2017-11-09
$600.00K
derived: sum of 2 quarters · filed 2017-11-09
$1.00M
10-Q · filed 2017-11-09
$1.60M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$300.00K
10-Q · filed 2017-08-10
$700.00K
10-Q · filed 2017-08-10
$1.00M
10-Q · filed 2016-08-09
$1.30M
derived: sum of 3 quarters · filed 2017-08-10
$1.70M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$500.00K
10-Q · filed 2017-05-15
$1.00M
derived: sum of 2 quarters · filed 2017-05-15
$1.40M
derived: sum of 3 quarters · filed 2017-05-15
$1.80M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17
$900.00K
derived: sum of 2 quarters · filed 2017-03-17
$1.30M
derived: sum of 3 quarters · filed 2017-03-17
$1.70M
10-K · filed 2017-03-17
2015-09-30$400.00K
10-Q · filed 2015-11-05
$800.00K
derived: sum of 2 quarters · filed 2015-11-05
$1.20M
10-Q · filed 2015-11-05
$2.40M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30$400.00K
10-Q · filed 2015-08-06
$800.00K
10-Q · filed 2015-08-06
$2.00M
derived: sum of 3 quarters · filed 2016-11-07
$2.40M
derived: sum of 4 quarters · filed 2016-11-07
2015-03-31$1.20M
10-Q · filed 2016-11-07
$400.00K
10-Q · filed 2015-05-06
$1.60M
derived: sum of 2 quarters · filed 2016-11-07
$2.00M
derived: sum of 3 quarters · filed 2016-11-07
$2.30M
derived: sum of 4 quarters · filed 2016-11-07
2014-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$800.00K
derived: sum of 2 quarters · filed 2016-03-15
$1.10M
derived: sum of 3 quarters · filed 2016-03-15
$1.30M
10-K · filed 2016-03-15
2014-09-30$400.00K
10-Q · filed 2015-11-05
$700.00K
derived: sum of 2 quarters · filed 2015-11-05
$900.00K
10-Q · filed 2015-11-05
$1.10M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$300.00K
10-Q · filed 2015-08-06
$500.00K
10-Q · filed 2015-08-06
$700.00K
derived: sum of 3 quarters · filed 2016-03-15
$1.00M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$200.00K
10-Q · filed 2015-05-06
$400.00K
derived: sum of 2 quarters · filed 2016-03-15
$700.00K
derived: sum of 3 quarters · filed 2016-03-15
$1.00M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$500.00K
derived: sum of 2 quarters · filed 2016-03-15
$800.00K
derived: sum of 3 quarters · filed 2016-03-15
$1.10M
10-K · filed 2016-03-15
2013-09-30$300.00K
10-Q · filed 2014-10-30
$600.00K
derived: sum of 2 quarters · filed 2014-10-30
$900.00K
10-Q · filed 2014-10-30
$1.17M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$300.00K
10-Q · filed 2014-08-07
$600.00K
10-Q · filed 2014-08-07
$874.50K
derived: sum of 3 quarters · filed 2015-03-02
$1.27M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$300.00K
10-Q · filed 2014-05-08
$574.50K
derived: sum of 2 quarters · filed 2015-03-02
$974.50K
derived: sum of 3 quarters · filed 2015-03-02
$1.37M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$274.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$674.50K
derived: sum of 2 quarters · filed 2015-03-02
$1.07M
derived: sum of 3 quarters · filed 2015-03-02
$1.50M
10-K · filed 2015-03-02
$1.52M
10-K · filed 2013-03-11
2012-09-30$400.00K
10-Q · filed 2013-11-07
$377.30K
10-Q · filed 2012-11-13
$800.00K
derived: sum of 2 quarters · filed 2013-11-07
$1.23M
10-Q · filed 2012-11-13
$1.54M
derived: sum of 4 quarters · filed 2013-11-07
2012-06-30$400.00K
10-Q · filed 2013-08-08
$435.40K
10-Q · filed 2012-08-14
$1.20M
10-Q · filed 2013-11-07
$848.20K
10-Q · filed 2012-08-14
$1.14M
derived: sum of 3 quarters · filed 2013-08-08
$1.57M
derived: sum of 4 quarters · filed 2013-08-08
2012-03-31$400.00K
10-Q · filed 2013-05-09
$737.50K
derived: sum of 2 quarters · filed 2013-05-09
$1.17M
derived: sum of 3 quarters · filed 2013-05-09
$1.70M
derived: sum of 4 quarters · filed 2013-05-09
2011-12-31$337.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$772.10K
derived: sum of 2 quarters · filed 2013-03-11
$1.30M
derived: sum of 3 quarters · filed 2013-03-11
$1.71M
10-K · filed 2013-03-11
$2.10M
8-K · filed 2012-08-15
2011-09-30$434.60K
10-Q · filed 2012-11-13
$963.50K
derived: sum of 2 quarters · filed 2012-11-13
$1.38M
10-Q · filed 2012-11-13
2011-06-30$528.90K
10-Q · filed 2012-08-14
$941.50K
10-Q · filed 2012-08-14
2010-12-31$889.00K
8-K · filed 2012-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
BIOVIE INC. (BIVI)United States$0.012B